More than 2 years since the original trial data for lecanemab in Alzheimer's disease was published,1 and over 1·5 years since approval by the US Food and Drug Administration, brain volume data have ...
The University of Indianapolis announced today that it has become part of the Age-Friendly University Global Network, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback